VRTX Vertex Pharmaceuticals
Vertex Pharmaceuticals earnings company data as of 4:45 AM ET 10/31
- 1 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 2 Nov | EPS | 0.38 | — | — |
| Rev | $3.43B | — | — | ||
| FY2026 Q2 | 3 Aug | EPS | 4.15 | 4.31 | Beat +3.9% |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by VRTX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- None no sales outside a trading plan
- $158M sold by 13 insiders under 10b5-1 plans
-
Ourania Tatsis EVP, Chief Reg. & Quality Off.Planned sale$787K 1,500 shares at $524.99 3.2% of stakeTraded Jul 2 Filed Jul 7
-
Duncan McKechnie EVP, Chief Commercial OfficerPlanned sale$800K 1,541 shares at $519.00 12% of stakeTraded Jul 2 Filed Jul 7
-
Joy Liu EVP and Chief Legal OfficerPlanned sale$416K 828 shares at $502.71 4.1% of stakeTraded Jul 1 Filed Jul 6
-
Carmen Bozic EVP and CMOPlanned sale$288K 596 shares at $482.50 3.7% of stakeTraded Jun 26 Filed Jun 30
-
Carmen Bozic EVP and CMOPlanned sale$471K 1,020 shares at $462.17 6% of stakeTraded Jun 18 Filed Jun 23
-
Carmen Bozic EVP and CMOPlanned sale$1.8M 4,062 shares at $450.00 19% of stakeTraded Jun 15 Filed Jun 17
-
Carmen Bozic EVP and CMOPlanned sale$785K 1,745 shares at $450.00 7.7% of stakeTraded Jun 5 Filed Jun 9
-
Joy Liu EVP and Chief Legal OfficerPlanned sale$364K 828 shares at $439.91 4% of stakeTraded Jun 1 Filed Jun 3
-
Carmen Bozic EVP and CMOPlanned sale$888K 1,974 shares at $450.00 8% of stakeTraded May 29 Filed Jun 2
-
Mark E. Bunnage EVP, Chief Scientific OfficerPlanned sale$15K 33 shares at $453.45 0.5% of stakeTraded May 15 Filed May 19
-
Carmen Bozic EVP and CMOPlanned sale$614K 1,354 shares at $453.45 5.2% of stakeTraded May 15 Filed May 19
-
Carmen Bozic EVP and CMOPlanned sale$3.1M 6,988 shares at $450.00 21% of stakeTraded May 12 Filed May 14
-
Joy Liu EVP and Chief Legal OfficerPlanned sale$469K 1,104 shares at $425.02 5.1% of stakeTraded May 1 Filed May 5
-
Sangeeta N. Bhatia DirectorPlanned sale$135K 318 shares at $423.73 6.1% of stakeTraded May 4 Filed May 5
-
Joy Liu EVP and Chief Legal OfficerPlanned sale$439K 978 shares at $449.17 4.3% of stakeTraded Apr 1 Filed Apr 3
Also filed in the last 12 months, not counted as buying or selling: 42 stock grants, 42 share withholdings for taxes, 8 option exercises, 4 sales back to the company, and 2 gifts.
SEC filings
Recent issuer filings from EDGAR, 8 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.